Eubel Brady & Suttman Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Eubel Brady & Suttman Asset Management Inc

  • $766 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021
SELL
$574.03 - $680.96 $72,327 - $85,800
-126 Closed
0 $0
Q2 2021

Aug 17, 2021
BUY
$472.8 - $558.54 $59,572 - $70,376
126 New
126 $60,000

Others Institutions Holding REGN

# of Institutions
1,532
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $78.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Eubel Brady & Suttman Asset Management Inc Portfolio

Follow Eubel Brady & Suttman Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eubel Brady & Suttman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eubel Brady & Suttman Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email